164 related articles for article (PubMed ID: 31149497)
1. Favorable response of colonic mixed adenoneuroendocrine carcinoma to streptozocin monotherapy.
Tagai N; Goi T; Morikawa M; Kurebayashi H; Kato S; Fujimoto D; Koneri K; Murakami M; Hirono Y; Noriki S; Katayama K
Int Cancer Conf J; 2017 Oct; 6(4):175-179. PubMed ID: 31149497
[TBL] [Abstract][Full Text] [Related]
2. [A case of mixed adenoneuroendocrine carcinoma of the transverse colon].
Kusakabe J; Miki A; Kobayashi H; Uryuhara K; Hashida H; Mizumoto M; Kaihara S; Hosotani R; Yamashita D
Gan To Kagaku Ryoho; 2014 Nov; 41(12):1826-8. PubMed ID: 25731343
[TBL] [Abstract][Full Text] [Related]
3. Long-term control with chemoradiation of initially metastatic mixed adenoneuroendocrine carcinoma of the rectum: a case report.
Semrau S; Agaimy A; Pavel M; Lubgan D; Schmidt D; Cavallaro A; Golcher H; Grützmann R; Fietkau R
J Med Case Rep; 2019 Mar; 13(1):82. PubMed ID: 30902067
[TBL] [Abstract][Full Text] [Related]
4. Two patients with rare mixed adenoneuroendocrine carcinomas of the rectum.
Gül-Klein S; Sinn M; Jurmeister PS; Biebl M; Weiß S; Rau B; Bläker H; Pratschke J; Aigner F
SAGE Open Med Case Rep; 2018; 6():2050313X18758816. PubMed ID: 29568525
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological and Prognostic Evaluations of Mixed Adenoneuroendocrine Carcinoma of the Colon and Rectum: A Case-Matched Study.
Watanabe J; Suwa Y; Ota M; Ishibe A; Masui H; Nagahori K; Tsuura Y; Endo I
Dis Colon Rectum; 2016 Dec; 59(12):1160-1167. PubMed ID: 27824701
[TBL] [Abstract][Full Text] [Related]
6. [Conversion Therapy Using Etoposide and Cisplatin Chemotherapy for Liver Metastases from Advanced Gastric Mixed Adenoneuroendocrine Carcinoma - A Case Report].
Inaba Y; Fujita M; Ninomiya R; Hashimoto D
Gan To Kagaku Ryoho; 2017 Nov; 44(12):1488-1490. PubMed ID: 29394677
[TBL] [Abstract][Full Text] [Related]
7. Mixed adenoneuroendocrine carcinoma of the colon progressed rapidly after hepatic rupture: report of a case.
Ito H; Kudo A; Matsumura S; Ban D; Irie T; Ochiai T; Nakamura N; Tanaka S; Tanabe M
Int Surg; 2014; 99(1):40-4. PubMed ID: 24444267
[TBL] [Abstract][Full Text] [Related]
8. [A case of a recurrent hepatic metastasis occurred after curative resection of ascending colon cancer and a hepatic metastasis responding completely to capecitabine plus bevacizumab].
Murayama M; Kohno T; Miyazawa M; Shimazaki A; Miyaki A; Usuda A; Asaka S; Yamaguchi K; Yokomizo H; Shiozawa S; Yoshimatsu K; Shimakawa T; Katsube T; Naritaka Y
Gan To Kagaku Ryoho; 2013 Nov; 40(12):2014-6. PubMed ID: 24393997
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis, Assessment, and Therapeutic Strategy for Colorectal Mixed Adenoneuroendocrine Carcinoma.
Tanaka T; Kaneko M; Nozawa H; Emoto S; Murono K; Otani K; Sasaki K; Nishikawa T; Kiyomatsu T; Hata K; Morikawa T; Kawai K; Watanabe T
Neuroendocrinology; 2017; 105(4):426-434. PubMed ID: 28641295
[TBL] [Abstract][Full Text] [Related]
10. Mixed adenoneuroendocrine carcinoma of the liver: A rare case report.
Yang JJ; Li ZP; Luo CL; Du Y; Lu QY; Li N; Li H; Yu TP; Huang XM
Mol Clin Oncol; 2020 Feb; 12(2):148-154. PubMed ID: 31929886
[TBL] [Abstract][Full Text] [Related]
11. [A case of colonic neuroendocrine carcinoma with severe liver dysfunction by multiple liver metastases successfully treated with hepatic arterial infusion].
Kikuchi A; Yamauchi S; Ono H; Kato S; Ishiguro M; Ishikawa T; Kobayashi H; Iida S; Uetake H; Higuchi T; Enomoto M; Sugihara K
Gan To Kagaku Ryoho; 2011 Nov; 38(12):2268-70. PubMed ID: 22202351
[TBL] [Abstract][Full Text] [Related]
12. Relapsed urachal carcinoma responding to first-line chemotherapy with capecitabine-oxaliplatin plus bevacizumab.
Hatano A; Wakaki K; Miyajima N; Komatsu S
IJU Case Rep; 2023 Nov; 6(6):345-348. PubMed ID: 37928300
[TBL] [Abstract][Full Text] [Related]
13. Mixed adenoneuroendocrine carcinoma with loss of HER2 positivity after trastuzumab-based chemotherapy for HER2-positive gastric cancer: a case report.
Nagata H; Tsujimoto H; Yaguchi Y; Kouzu K; Itazaki Y; Ishibashi Y; Tsuchiya S; Sugihara T; Ito N; Harada M; Nomura S; Utsumi Y; Shimazaki H; Kishi Y; Ueno H
Surg Case Rep; 2020 Jan; 6(1):5. PubMed ID: 31916037
[TBL] [Abstract][Full Text] [Related]
14. [Effective chemotherapy with bevacizumab/FOLFOX4 for neuroendocrine carcinoma of the ascending colon - a case study].
Tanabe H; Takase T; Morimoto D; Tanaka Y; Shibata A; Yaguchi T
Gan To Kagaku Ryoho; 2014 May; 41(5):661-4. PubMed ID: 24917018
[TBL] [Abstract][Full Text] [Related]
15. Mixed adenoneuroendocrine carcinoma of the colon: molecular pathogenesis and treatment.
Vanacker L; Smeets D; Hoorens A; Teugels E; Algaba R; Dehou MF; De Becker A; Lambrechts D; De Greve J
Anticancer Res; 2014 Oct; 34(10):5517-21. PubMed ID: 25275049
[TBL] [Abstract][Full Text] [Related]
16. XELOX (capecitabine plus oxaliplatin): active first-line therapy for patients with metastatic colorectal cancer.
Cassidy J; Tabernero J; Twelves C; Brunet R; Butts C; Conroy T; Debraud F; Figer A; Grossmann J; Sawada N; Schöffski P; Sobrero A; Van Cutsem E; Díaz-Rubio E
J Clin Oncol; 2004 Jun; 22(11):2084-91. PubMed ID: 15169795
[TBL] [Abstract][Full Text] [Related]
17. Phase II Trial of Preoperative Radiation With Concurrent Capecitabine, Oxaliplatin, and Bevacizumab Followed by Surgery and Postoperative 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX), and Bevacizumab in Patients With Locally Advanced Rectal Cancer: 5-Year Clinical Outcomes ECOG-ACRIN Cancer Research Group E3204.
Landry JC; Feng Y; Prabhu RS; Cohen SJ; Staley CA; Whittington R; Sigurdson ER; Nimeiri H; Verma U; Benson AB
Oncologist; 2015 Jun; 20(6):615-6. PubMed ID: 25926352
[TBL] [Abstract][Full Text] [Related]
18. [Analysis on safety and preliminary efficacy of dose-modified regimen of 5-fluorouracil plus oxaliplatin and irinotecan (FOLFOXIRI) in advanced colorectal cancer].
Cai Y; Deng R; Hu H; Zhang J; Ling J; Wu Z; Yang L; Li J; Deng Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Sep; 21(9):1045-1050. PubMed ID: 30269326
[TBL] [Abstract][Full Text] [Related]
19. [Long-term survival of a case of juvenile colon cancer with multiple liver metastases successfully treated by multidisciplinary therapy].
Kubo H; Nishiyama M; Tada K; Miyahara M; Hasegawa H
Gan To Kagaku Ryoho; 2013 Jan; 40(1):99-102. PubMed ID: 23306928
[TBL] [Abstract][Full Text] [Related]
20. The clinical and cost-effectiveness of oxaliplatin and capecitabine for the adjuvant treatment of colon cancer: systematic review and economic evaluation.
Pandor A; Eggington S; Paisley S; Tappenden P; Sutcliffe P
Health Technol Assess; 2006 Nov; 10(41):iii-iv, xi-xiv, 1-185. PubMed ID: 17049138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
